Walleye Trading LLC Aclaris Therapeutics, Inc. Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.56 - $10.95 $89,235 - $148,952	-13,603 Reduced 29.36%	32,724 $224,000
Q2 2023 Aug 14, 2023	BUY	$7.89 - $10.64 $365,520 - $492,919	46,327 New	46,327 $480,000
Q4 2022 Feb 14, 2023	BUY	$14.33 - $18.37 $14,086 - $18,057	983 Added 4.68%	22,009 $346,000
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $274,809 - $383,093	21,026 New	21,026 $331,000
Q3 2019 Nov 14, 2019	SELL	$0.79 - $2.47 $43,450 - $135,850	-55,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.13 - $7.06 $117,150 - $388,300	55,000 New	55,000 $120,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.